[ad_1]
“We have received another offer from the EC to express our opinion on the purchase of the CureVac vaccine. Lithuania could acquire 1.4 million. And diversify the purchase of vaccines, taking into account previous decisions. We offer to approve and acquire it,” said Aurelijus Veryga , the Acting Minister of Health, who presented the issue during the Government meeting.
The European Commission last week signed a contract with the German pharmaceutical company CureVac for the development of the COVID-19 vaccine for 225 million euros. supply of doses and another 180 million. dose reservation on behalf of EU members.
Sigismund Gedvila / 15min photo / Aurelijus Veryga
Lithuania must inform the European Commission of its decision to participate in this agreement before Tuesday.
This is the fifth vaccine that Lithuania seeks to buy from other countries.
The government previously decided to buy 1.86 million from the pharmaceutical company AstraZeneca. coronavirus vaccines, 1.24 million from Janssen Pharmaceutica NV. dose, but this amount will be reduced to 700 thousand. It is planned to acquire 1.5 million from the pharmaceutical companies Sanofi and GSK. coronavirus vaccines, 1.24 million from BioNTech and Pfizer. vaccine dose.
The Cabinet of Ministers has also decided that Lithuania, together with other European Union countries, will participate in the procurement of all COVID-19 vaccines under development, which are being negotiated by the European Commission. In this way, the aim is to ensure that Lithuania has a sufficient supply of effective vaccines.
The government is determined to buy enough to vaccinate 70 percent. population of the country.
[ad_2]
